Debt-ridden Indian vaccine maker Panacea to exit hospitals
This article was originally published in Scrip
Executive Summary
The financially stretched Indian vaccines producer Panacea Biotec has put on the block its interest in an ambitious hospital enterprise as part of efforts to satisfy certain terms of a debt revamp plan.